- cafead Nov 15, 2024 at 11:12: AM
via As quickly as they rose to prominence during the pandemic, many biotechs fell just as rapidly back down to earth.
When pharma’s R&D push peaked, hundreds of vaccines and treatments were in development to combat the novel coronavirus. And while the remobilization turned once-obscure biotechs like Moderna into household names, a host of other companies that had suddenly emerged into the spotlight ultimately faded as their candidates faltered.
article source
When pharma’s R&D push peaked, hundreds of vaccines and treatments were in development to combat the novel coronavirus. And while the remobilization turned once-obscure biotechs like Moderna into household names, a host of other companies that had suddenly emerged into the spotlight ultimately faded as their candidates faltered.
article source